Publications by authors named "Hans-Peter Dauben"

Claim this Profile
E
Editorial: Translation of health technology reassessment and its outputs of disinvestment, de-implementation and de-adoption of drugs and medical devices in practice-what have we learned?
Rosmin Esmail, Nora Ibargoyen-Roteta, Maximilian Otte, Iñaki Gutiérrez-Ibarluzea, Roberta Joppi, Hans-Peter Dauben

Front Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contextual factors in value-based decision support to enhance health technologies adoption: the case of biosimilars.
Maximilian Otte, Zoltán Kaló, Hussain Abdulrahman Al-Omar, Meindert Boysen, Yingyao Chen, Hans-Peter Dauben

Front Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building capacity in horizon scanning, early awareness, and disinvestment: a framework for education and training.
Maximilian Otte, Rosmin Esmail, Nora Ibargoyen-Roteta, Iñaki Gutiérrez-Ibarluzea, Hans-Peter Dauben

Int J Technol Assess Health Care· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers.
Maximillian Otte, Hans Peter Dauben, Jeonghoon Ahn, Iñaki Gutierrez Ibarluzea, Michael Drummond

Expert Rev Pharmacoecon Outcomes Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Issues of Platform Trials: Learnings from EU-PEARL.
Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, Franz König, Martin Posch, Hans-Peter Dauben

Clin Pharmacol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agencies.
Nora Ibargoyen-Roteta, Lorea Galnares-Cordero, Gaizka Benguria-Arrate, Kelly Rocío Chacón-Acevedo, María Paula Gutiérrez-Sepulveda, Hans Peter Dauben

Front Public Health· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Better Pharmaceutical Provision in Europe-Who Decides the Future?
Denis Horgan, Tanja Spanic, Kathi Apostolidis, Giuseppe Curigliano, Joanna Chorostowska-Wynimko, Hans-Peter Dauben

Healthcare (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems.
Entela Xoxi, Filippo Rumi, Panos Kanavos, Hans-Peter Dauben, Iñaki Gutierrez-Ibarluzea

Front Med Technol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new HInT in the publishing panorama: an interesting opportunity to those working on health innovation and technologies.
Antonio Migliore, Hans-Peter Dauben, Iñaki Gutierrez Ibarluzea, Brendon Kearney, Lisa Kurylowicz

GMS Health Innov Technol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HTA Metro Map: a patient centred model for optimizing the decision making process.
Marco Chiumente, Khalid M Kamal, Hans-Peter Dauben, Rainer Riedel, Inaki Gutierrez-Ibarluzea

GMS Health Innov Technol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ICHI-International Classification of Health Interventions : A balancing act between the demands of statistics and reimbursement].
Albrecht Zaiss, Hans-Peter Dauben

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Life Cycle of Health Technologies. Challenges and Ways Forward.
Iñaki Gutiérrez-Ibarluzea, Marco Chiumente, Hans-Peter Dauben

Front Pharmacol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Learning-Adapting-Leveling model: from theory to hypothesis of steps for implementation of basic genome-based evidence in personalized medicine.
Jonathan A Lal, Anil Vaidya, Iñaki Gutiérrez-Ibarluzea, Hans-Peter Dauben, Angela Brand

Per Med· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting decision making in cross-border regions: a health technology assessment tool for hospitals.
Saskia Knies, Gloria Lombardi, Matt Commers, Hans-Peter Dauben, Silvia Evers

Int J Technol Assess Health Care· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAES recommendations on methodology of innovation management in endoscopic surgery.
Edmund A M Neugebauer, Monika Becker, Gerhard F Buess, Alfred Cuschieri, Hans-Peter Dauben

Surg Endosc· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health technology assessment: a perspective from Germany.
Frank-Ulrich Fricke, Hans Peter Dauben

Value Health· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health promotion and disease prevention as a complement to community health indicators. Working group 1.
Hans-Peter Dauben, Olav Helge Førde, Marlène Laeubli Loud, Sven-Olof Isacsson, Fred Paccaud

Int J Technol Assess Health Care· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis